Webinar
Hindsight is so 2020: Getting Ahead of CNS Trial Enrollment in a Rapidly Changing Clinical Landscape
The past six months have highlighted both existing and unexpected enrollment challenges, as sponsors, CROs, and sites have been pressed to evolve their recruitment strategies. Join us as Rho experts discuss their approach to adapting CNS trial enrollment to a rapidly changing clinical landscape. This webinar will address:
- Optimizing site feasibility, recruitment, and selection
- Embracing decentralized models and technologies with regard to patient enrollment, retention, and visit compliance
- The role of patient and caregiver centricity in protocol design, implementation, and data collection
Amy Goodykoontz
Senior Project Manager
A creative, purpose-driven project manager with over 12 years of global clinical trial experience, Amy Goodykoontz got her first taste of clinical research in 2008 and she’s been hooked ever since. Over the span of her career, Ms. Goodykoontz has supported multiple Phase 1 – Phase 3 study protocols emphasizing complex study designs, including trials with single and multiple-dose escalations, central adjudication, interim analyses, long-term extensions, and data and safety monitoring boards. Ms. Goodykoontz excels in the management of specialized vendors for biomarker and genetic testing, including those that require cerebral spinal fluid analysis, positron emission tomography, magnetic field imaging,…
Brett Gordon
Executive Director, Project Delivery
With more than 20 years of clinical development experience at both CROs and sponsor companies, Brett Gordon brings the individual focus a project requires while also providing a wider perspective of the clinical development landscape as a whole. Working on both domestic and international trials of varying sizes and complexity, Mr. Gordon provides extensive knowledge of clinical operations, including initial development plan formulation, protocol writing, trial implementation, monitoring and delivery, clinical study report writing, and marketing applications. Mr. Gordon has managed trials through the clinical development lifecycle from first-in-man, single-center Phase 1 trials to large 100+ center multinational Phase 3…
Natalia Marder, M.D., Ph.D.
Project Director
Dr. Natalia Marder has more than 14 years of clinical development experience in the CRO environment, including managing multiple global studies, as well as both mega-trials and small trials with niche biopharma companies. For 10 years, she has been focused on the operational management and clinical development of compounds for the treatment of numerous neurodegenerative disorders, including psychiatric diseases, neuropathies, pain, neurogenic bladder, and Parkinson’s disease (motor and non-motor symptoms). Her areas of expertise also include collaboration with the spina bifida associations and networks, controlled substance supply management, and medical review of the data collected in the clinical trials. Dr.…